Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)
China flag China · Delayed Price · Currency is CNY
5.93
-0.17 (-2.79%)
Apr 28, 2026, 3:04 PM CST

SHE:300639 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
696.76712.36764.931,025521.97390.96
Short-Term Investments
-250.29----
Trading Asset Securities
242.050.63307.05387.06677.14860
Cash & Short-Term Investments
938.81963.271,0721,4121,1991,251
Cash Growth
3.63%-10.14%-24.07%17.74%-4.14%376.86%
Accounts Receivable
861.881,0991,8912,7251,116576.86
Other Receivables
12.1210.9813.5616.3214.539.57
Receivables
8741,1101,9042,7421,131586.43
Inventory
79.4865.6699.56118.74147.1496.3
Prepaid Expenses
-0.015.115.5423.3712.01
Other Current Assets
83.7887.0996.13112.4451.9516.42
Total Current Assets
1,9762,2263,1774,4002,5521,962
Property, Plant & Equipment
1,3261,4081,4371,3171,168598.45
Long-Term Investments
330.21545.71533.12521.98273.8175.98
Other Intangible Assets
251.14259.28249.58185.21100.14100.72
Long-Term Deferred Tax Assets
75.1286.32195.35180.2529.221.07
Long-Term Deferred Charges
61.2460.979.9581.6182.6250.65
Other Long-Term Assets
263.0837.6153.554.8925.5847.97
Total Assets
4,2824,6235,7266,7414,2312,857
Accounts Payable
95.03106.75143.67466.69221.1586.2
Accrued Expenses
64.0972.6585.83399.86174.9698.07
Short-Term Debt
121.632.1298.48151.575.27
Current Portion of Leases
5.397.918.8610.486.79-
Current Income Taxes Payable
14.728.378.1352.7194.8810.83
Current Unearned Revenue
12.5714.868.9322.1613.1624.69
Other Current Liabilities
197.36209.46180.412.4615.157.96
Total Current Liabilities
390.16441.55507.921,363677.59303.02
Long-Term Debt
95.5752.7928.27---
Long-Term Leases
4.35.1917.430.5326.860.17
Long-Term Unearned Revenue
7.519.1511.8214.1316.5618.91
Long-Term Deferred Tax Liabilities
55.7167.0761.6106.1435.360.58
Other Long-Term Liabilities
0.510.690.05---
Total Liabilities
553.76576.44627.051,514756.37322.69
Common Stock
646.5646.5649.15439.52293.89235.38
Additional Paid-In Capital
726.71785.49877.521,1901,2801,361
Retained Earnings
2,4232,5513,2473,2581,634851.33
Treasury Stock
-110.15-65.13-100-149.99-99.99-50.02
Comprehensive Income & Other
154.71191.85187.26169.8486.73-7.63
Total Common Equity
3,8414,1094,8614,9073,1942,391
Minority Interest
-112.19-62.9237.46320.38280.63143.74
Shareholders' Equity
3,7294,0475,0995,2283,4752,534
Total Liabilities & Equity
4,2824,6235,7266,7414,2312,857
Total Debt
106.2687.5156.65139.49185.1575.44
Net Cash (Debt)
832.55875.761,0151,2721,0141,176
Net Cash Growth
2.55%-13.75%-20.20%25.48%-13.74%348.50%
Net Cash Per Share
1.301.36-1.931.541.92
Filing Date Shares Outstanding
627.62635.3-651.68655.3659
Total Common Shares Outstanding
627.62635.3-651.68655.3659
Working Capital
1,5861,7842,6693,0371,8751,659
Book Value Per Share
6.126.47-7.534.873.63
Tangible Book Value
3,5903,8504,6124,7223,0942,290
Tangible Book Value Per Share
5.726.06-7.254.723.47
Buildings
-1,1151,070991.09786.57424.56
Machinery
-701.8683.89600.83521.92281.13
Construction In Progress
-232.59171.3858.6238.2949.71
Source: S&P Global Market Intelligence. Standard template. Financial Sources.